Topic Listing for BIOCLINICA INC

Acquired Intangible Assets Acquisitions
Affiliates Significant Control Over Common Stock Allowing Them Aggregated Option Exercises 2004 Year-end Values
Aggregated Option Exercises 2005 Year-end Values Allowance Doubtful Accounts
Amendment Application Critical Accounting Policies Estimates
Approval Amended Restated 2002 Stock Incentive Plan Basis Presentation
Because Not Intend Pay Dividends Stockholders Benefit Investment Beneficial Ownership Reporting Compliance
Bio-imaging Technologies Announces 2005 Financial Results Bio-imaging Technologies Announces Year-end 2005 Financial Results
Bio-imaging Technologies Inc Bioclinica Inc
Board Determination Independence Board Directors
Board Directors Recommends Vote Ratification Appointment Pricewaterhousecoopers Llp Business Segments
Business Services Cancer Therapeutics
Capital Lease Obligations Capitalized Software Development
Capmed Division Capmed Division Not Reach Profitability
Cardiovascular Therapeutics Cash Equivalents
Central Nervous System Neurovascular Therapeutics Central Nervous System Therapeutics
Certain Provisions Charter Delaware Law Make Takeover Difficult Certain Relationships Related Transactions
Certification Certification Pursuant 302 Sarbanes-oxley Act 2002
Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act Changes Critical Accounting Policies Estimates
Changes Governmental Regulation Decrease Need Services Provide Negatively Changes Outsourcing Trends Pharmaceutical Biotechnology Industries Adversely Affect
Cns Neurovascular Disorders Code Business Conduct Ethics
Commitments Committees Meetings Board
Communicating Independent Directors Compensation Committee Report Executive
Compensation Directors Competition
Comprehensive Income Consent Independent Registered Public Accounting Firm
Consolidated Statements Operations Contracted Committed Backlog Not Indicative Future Results
Controls Procedures Core Laboratory Services
Corporate Governance Guidelines Corporation Annual Meeting Stockholders
Critical Accounting Policies Estimates Risks Departure Directors Principal Officers Election Appointment
Depend Small Number Industries Clients Business Loss Such Derivatives
Description Business Diagnostic Imaging Agents
Director Candidates Directors Executive Officers
Earnings Per Share Employee Benefit Plan
Employees Employment Contracts Termination Change-in-control Arrangements
Engage Future Acquisitions Expensive Time Consuming Not Realize Entry Material Definitive Agreement
Eps 005 Per Share 2006 Record Backlog 752 Equity
Equity Compensation Plan Information Estimates
Exact Name Issuer Specified Charter Exact Name Registrant Specified Charter
Exchange Act 1934 Amendment Executive Compensation
Executive Officers Exhibits
Existing Contracts Experienced Substantial Expansion Past Fail Properly Manage Business
Exposed Liability Claims Result Involvement Clinical Trials Failure Compete Effectively Competitive Industry Cause Revenues Decline
Failure Compete Effectively Industry Cause Revenues Decline Failure Comply Existing Regulations Result Increased Costs Complete
Fair Value Financial Instruments Field Test Milestones Implementation Schedule
Financial Results Financial Statements Exhibits
Foreign Currency Risk Foreign Currency Risks
Foreign Currency Translation Foreign Operations
Form 10-q Former Name Address Changed Since Last Report
Forward Looking Statements Functional Currency
General General Provisions
Goodwill Other Intangible Assets Government Regulation
Governmental Agencies Not Accept Data Analyses Generated Services Held 2005
Held 2006 Householding Annual Meeting Materials
Income Taxes Incur Financial Losses Because Contracts Delayed Terminated Reduced
Independent Registered Public Accounting Firm Fees Other Matters Index
Individual Grants Information Management Services
Intellectual Property Interest Rate Risk
Investments Exposed Credit Risk Issuers Telephone Number Including Area Code
Legal Proceedings Loss Key Personnel Failure Attract Retain Additional Cause
Major Customers Market Registrants Common Equity Related Stockholder Matters Issuer
Market Trends Marketing Sales
Miscellaneous Musculoskeletal Therapeutics
Name Person Filing Proxy Statement Other Registrant Nasdaq National Market
New Plan Benefits Newtown Pennsylvania 18940-1721
Option Grants 2004 Option Grants 2005
Other Events Other Information
Other Matters Other Services
Overview Part
Part Other Information Percentage Ownership Voting Power Price Common Stock Decrease
Pharmaceutical Contract Services Pharmaceutical Services Division
Phase Clinical Trials Phase Post Approval Studies
Please Date Sign Return Proxy Card Earliest Convenience Pre-approval Policies Procedures
Press Release Principal Accountant Fees Services
Principles Consolidation Properties
Property Equipment Proxy Properly Executed Voted Manner Directed Herein Undersigned
Proxy Statement Quantitative Qualitative Disclosures Market Risk
Quarterly Period 2005 Quarterly Period 2006
Quarterly Results Ratification Appointment Independent Registered Public Accounting Firm
Recently Issued Accounting Statements Reclassifications
Record Backlog 706 Eps Rises Cents Registrants Telephone Number Including Area Code
Related Party Transactions Report Audit Committee
Report Independent Registered Public Accounting Firm Required Vote
Results Operations Results Operations Financial Condition
Return Profitability Record Backlog 656 Revenue Recognition
Revenues Earnings Operating Costs Exposed Exchange Rate Fluctuations Sarbanes-oxley Act 2002
Securities Registered Pursuant Exchange Act Security Ownership Certain Beneficial Owners Management Related Stockholder
Shares Common Stock Eligible Public Sale Negative Impact Signature
Signatures Significant Clients
Stock Options Stock Performance Graph
Stockholders Proposals Submission Matters Vote Security Holders
Summary Compensation 2004 Summary Compensation 2005
Summary Compensation Table Summary Federal Income Tax Consequences
Table Contents Target Markets
Tax Considerations Trading Common Stock Volatile Result Substantial Declines Market
Transactions Covance Inc Transactions Quintiles Inc
Unregistered Sales Equity Securities Proceeds Year-end Option Values
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki